Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Menstrual disorder, Oligomenorrhoea, SARS-CoV-2 test
Clinical narrative: Have not been having regular periods anymore; Still have not had a period after receiving my last dose; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Nov2021 as dose 3 (booster), single (Lot number: FE3590) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Epilepsy" (unspecified if ongoing); "Childhood asthma" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: DEPAKOTE; FOLIC ACID; VITAMIN D [COLECALCIFEROL]. Past drug history included: Cephalexin, reaction(s): "known allergies: cephalexin", notes: known allergies: cephalexin; Bactrim, reaction(s): "known allergies: Bactrim", notes: known allergies: Bactrim. Vaccination history included: BNT162b2 (DOSE 2, SINGLE, Batch/Lot No: ER8737, Location of injection: Arm Left), administration date: 31Mar2021, when the patient was 38-year-old, for COVID-19 immunization, reaction(s): "have not been having regular periods anymore"; BNT162b2 (DOSE 1, SINGLE, Batch/Lot No: EN6208, Location of injection: Arm Left), administration date: 09Mar2021, when the patient was 38-year-old, for COVID-19 immunization, reaction(s): "have not been having regular periods anymore". The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "Have not been having regular periods anymore"; OLIGOMENORRHOEA (non-serious) with onset 2021, outcome "not recovered", described as "Still have not had a period after receiving my last dose". The events "have not been having regular periods anymore" and "still have not had a period after receiving my last dose" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of menstrual disorder, oligomenorrhoea.  Additional information: Serious: No, Seriousness criteria-Results in death: No, Seriousness criteria-Life threatening: No, Seriousness criteria- Caused/prolonged hospitalization: No, Seriousness criteria-Disabling/Incapacitating: No, Seriousness criteria-Congenital anomaly/birth defect: No. There were no other vaccines in four weeks. Other medications in two weeks: Depakote, Folic Acid, Multivitamin, Vitamin D. Ever since receiving her COVID vaccines the patient had not been having regular periods anymore. After her initial COVID vaccine she thought it could just be a coincidence but after she received her subsequent doses it was apparent that it was related. She still had not had a period after receiving her last dose & her husband & her were hoping to have another child. Her PCP had done lab work & found no abnormal hormone levels or other factors that would indicate any other issues or early menopause etc. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Device Date: 29Jun2022  No follow-up attempts are possible. No further information is expected.